Arbutus Biopharma (ABUS) Other Accumulated Expenses (2013 - 2015)

Arbutus Biopharma has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $745000.0 for Q2 2015.

• Other Accumulated Expenses for Q2 2015 came in at $745000.0, up 169.93% year-over-year; the trailing twelve-month figure through Jun 2015 was $745000.0 (up 169.93% YoY), and the FY2014 annual result was $226000.0, down 71.57% from the prior year.
• Other Accumulated Expenses came in at $745000.0 for Q2 2015 at Arbutus Biopharma, down from $1.3 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.3 million in Q1 2015 to a low of $226000.0 in Q4 2014.
• The 3-year median for Other Accumulated Expenses is $510000.0 (2014), against an average of $603000.0.
• Across the five-year window, Other Accumulated Expenses tumbled 71.57% in 2014 and surged 169.93% in 2015, its largest moves.
• Arbutus Biopharma's Other Accumulated Expenses stood at $795000.0 in 2013, then sank by 71.57% to $226000.0 in 2014, then jumped by 229.65% to $745000.0 in 2015.
• The last three Other Accumulated Expenses figures came in at $745000.0 (Q2 2015), $1.3 million (Q1 2015), and $226000.0 (Q4 2014), per Business Quant data.